Skip to content

Pharmacovigilance

Vigilance is our key for patient safety. Patient safety is our primary and main objective!

Statistics & Data Analysis

We choose the right statistical tool and computational model to analyse your data.

Clinical Operations

We streamline clinical operations to provide efficacious solutions for complex projects.

Medical Consulting

Exceptional medical consultations to pharmaceutical and medical device companies!

Medical Writing

Our state of the art medical writing deliverables stand out!

Research & Development

We support drug development pipelines from benchside to "market"side.

Quality Assurance

Top-notch services are our goal. Quality is the essence of success.

Don't Delay!

Don't delay any longer. Schedule your consultation with our team today!

Statistics & Data Analysis

Medical Statistics

MD Pharma Consulting Group knows what the clinical study needs for statistical analysis. We choose the right statistical tools and deliver accurate interim, end of trial, and post-hoc analysis of our client’s clinical study results to reflect true efficacy outcomes.

Analysis of Safety Outcomes

  • MD Pharma Consulting Group tracks the safety data of our client’s clinical study:
  • Analyses the safety outcomes as per PT and SOC
  • Looks for sector map changes
  • Analyses the incidence rate of the adverse events and serious adverse events
  • Looks for differences in the incidence rate as per demographic and epidemiologic variables as age, gender, geographical location, etc.
  • Detects, evaluates, and prioritizes safety signals.

Analysis of Survival Outcomes

MD Pharma Consulting Group is an expert in Cancer Clinical Trials. We collect the recurrence, 1, 3, and 5-year disease free survival, and overall survival results of our client’s clinical study, and analyse them with the appropriate statistical tools to reflect true survival outcomes.

Analysis of Health Economics Outcomes

The support of MD Pharma Consulting Group for our clients' products continues for years after authorization by the regulatory agencies. We support our clients' products lifecycle management by helping our client make informed economic decisions. MD Pharma Consulting Group:

  • Studies the market providing updated systematic reviews and meta-analyses of our clients' products and their comparators.
  • Studies the burden of illness.
  • Applies various economic modeling techniques: Decision Tree and Modified Markov Chain Simulation Model.
  • Studies different case scenarios to assess uncertainty in economic evaluations with 1-way and 2-way sensitivity analyses.
  • Measures HRQoL and utility with the European Quality of Life-5 Dimensions (EQ-5D) tool and other utility measurement methods.
  • Calculates Quality adjusted life years (QALYs).
  • Provides cost-effectiveness analysis, cost-utility analysis, cost-benefit analysis, and budget impact analysis.

Analysis of Biomedical Research Outcomes

MD Pharma Consulting Group knows what the lab study needs for statistical analysis. We choose the right statistical tools and deliver accurate statistical analysis of our client’s lab study results to reflect true research outcomes.

Clinical Services

Professional Training

Contact Us Today!

Evaluating your Pharmacovigilance or Data Management options? Call us today to learn how MD Pharma Consulting Group can help you take the risk out of your work.